Metformin vs. Glimepiride

See how Metformin and Glimepiride compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Metformin is usually the first medication prescribed for type 2 diabetes, while glimepiride is often added later to lower blood sugar further.

  • Metformin carries a much lower risk of low blood sugar on its own, but glimepiride can cause hypoglycemia because it pushes the pancreas to release more insulin.

  • Both drugs are inexpensive generics that work through completely different mechanisms, and doctors sometimes prescribe them together for added control.

Metformin vs. Glimepiride Drug Summary

Metformin

Metformin is a biguanide used to control blood sugar in adults and children with type 2 diabetes. It works by lowering glucose production in the liver and improving the body's response to insulin, and it comes as a tablet or oral solution taken with meals.

Glimepiride

Glimepiride is a sulfonylurea used alongside diet and exercise to control blood sugar in adults with type 2 diabetes. It works by stimulating the pancreas to release more insulin and is taken as a single tablet once daily.

Metformin vs. Glimepiride Side Effects

Metformin

Most common
asthenia (>5%)
diarrhea (>5%)
nausea/vomiting (>5%)
flatulence (>5%)

Glimepiride

Most common
asthenia (>5%)
hypoglycemia (>5%)
dizziness (>5%)
headache (>5%)

Metformin vs. Glimepiride Dosage

Metformin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 500 mg twice daily Week 1
Maximum dose 500 mg once daily Week 1
Dose changes 2 increases As tolerated

Glimepiride

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 1 mg once daily Same as starting
Dose changes None Fixed dose

Metformin vs. Glimepiride Indications

Metformin

Metformin is FDA-approved for blood sugar control in adults and children age 10 and older with type 2 diabetes. It is also used off-label for polycystic ovary syndrome and for weight management in people with prediabetes.

  • Type 2 diabetes in adults

  • Type 2 diabetes in children 10 and older

  • Off-label: polycystic ovary syndrome (PCOS)

  • Off-label: prediabetes and weight management

Glimepiride

Glimepiride is FDA-approved for blood sugar control in adults with type 2 diabetes when diet and exercise alone are not enough. It is not approved for type 1 diabetes or diabetic ketoacidosis.

  • Type 2 diabetes in adults

  • Used as an adjunct to diet and exercise

  • Not approved for type 1 diabetes

  • Not approved for diabetic ketoacidosis

Metformin vs. Glimepiride Pros and Cons

Metformin

Metformin is considered first-line therapy for type 2 diabetes because it lowers blood sugar effectively with a low risk of hypoglycemia on its own. It comes in several forms and dosing schedules, which makes it easier to fit into different routines and tolerance levels.

Pros

  • First-line therapy recommended by major diabetes guidelines

  • Very low risk of hypoglycemia when used alone

  • Available as immediate-release, extended-release, and liquid forms

Cons

  • Common gastrointestinal side effects like diarrhea and nausea

  • Boxed warning for rare but serious lactic acidosis

  • Not recommended for people with severe kidney problems

  • Needs to be paused before certain contrast imaging procedures

Glimepiride

Glimepiride lowers blood sugar quickly by increasing insulin release from the pancreas, but that same mechanism brings a real risk of hypoglycemia and weight gain. It is typically added on to metformin rather than used as a first choice.

Pros

  • Fast, predictable blood-sugar-lowering effect

  • Simple once-daily dosing

  • Effective when added to metformin for extra control

Cons

  • Can cause hypoglycemia, sometimes severe

  • Linked to weight gain, unlike metformin

  • Older studies raised concerns about cardiovascular mortality

  • Not for use in people with G6PD deficiency due to anemia risk

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.